Researchers with the Autism Genome Project are calling for the broad use of a relatively new type of genetic test – for copy number variants (CNVs) – as the next step in individualized diagnosis and treatment of autism.
A review of more than 29,000 studies identified 27 autism therapies as worthy to be called "evidence-based." This is up from 24 autism therapies that the authors identified as solidly backed by research in their first review, published in 2008.
The year 2013 brought signs of a gratifying maturation in autism research. This went beyond the unmistakable increase in the sheer number of autism studies making headlines. Many of the year’s most important advances used new technologies and built on the foundation of knowledge established by years of investment in basic research.
POV by developmental-behavioral pediatrician Paul Wang, Autism Speaks’ senior vice president for medical research.
Autism Speaks is pleased to announce the awarding of three additional 2013 Weatherstone Predoctoral Fellowships. These fellows join six others whose projects were announced in March. Recipients pursue two-year projects under the mentorship of leading investigators in the field.
NEW YORK, N.Y. (October 29, 2013) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced three additional recipients to the fifth class of Weatherstone Predoctoral Fellows funded by the Stavros Niarchos Foundation. The fellowship program focuses on developing rising talent within the autism research community.